Cargando…

P386: COMPARISON OF THE PHARMACOKINETICS OF THE LIQUID AND THE LYOPHILIZED FORMULATIONS OF PEGASPARGASE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Detalles Bibliográficos
Autores principales:	Karachunskiy, Alexander, Kovalenko, Sergey, Lebedev, Vladimir, Plaksina, Olga, Ponomareva, Natalia, Seif, Vanessa, Meng, Qian, Grankov, Sergey, Simonot, Lorene, Fechina, Larisa, Dinikina, Yulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428428/ http://dx.doi.org/10.1097/01.HS9.0000968452.19800.b2

Ejemplares similares

Development of a Lyophilized Formulation of Pegaspargase and Comparability Versus Liquid Pegaspargase
por: Faschinger, Alexander M., et al.
Publicado: (2019)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Treatment of Children with Advanced-Stage Lymphoblastic Lymphoma with Pegaspargase
por: Yu-tong, Zhang, et al.
Publicado: (2014)

Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase
por: Tang, Elizabeth R., et al.
Publicado: (2018)

Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia
por: Schulte, Rachael, et al.
Publicado: (2021)

386 corales = 386 chorales /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1968)

Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review
por: Bender, Cynthia, et al.
Publicado: (2021)

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia
por: Nookala Krishnamurthy, Manjunath, et al.
Publicado: (2020)

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
por: Bassan, Renato, et al.
Publicado: (2023)

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation
por: Robbie, Gabriel J., et al.
Publicado: (2014)

Salvage treatment in IDH1 mutated acute lymphoblastic leukemia with venetoclax plus methotrexate and pegaspargase: A case report
por: Li, Dan, et al.
Publicado: (2023)

Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002
por: Karachunskiy, Alexander, et al.
Publicado: (2019)

Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
por: Franzé, Silvia, et al.
Publicado: (2018)

Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters
por: Degobert, Ghania, et al.
Publicado: (2021)

Pegaspargase Induced Hypertriglyceridemia Resulting in Severe Fatal Pancreatitis
por: Vyas, Neil, et al.
Publicado: (2015)

Rational design of heat stable lyophilized rotavirus vaccine formulations
por: Madan, Madhu, et al.
Publicado: (2018)

A386G polymorphism and infertility
por: Wiwanitkit, Viroj
Publicado: (2010)

Novelle NetWare 386 : manual de referencia
por: Sheldon, Tom
Publicado: (1992)

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
por: Mikhailova, Ekaterina, et al.
Publicado: (2022)

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
por: Hu, Xingdi, et al.
Publicado: (2019)

Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies
por: Yu, Yinglan, et al.
Publicado: (2018)

The Influence of Formulation and Manufacturing Process Parameters on the Characteristics of Lyophilized Orally Disintegrating Tablets
por: Jones, Rhys J., et al.
Publicado: (2011)

Detection of Collapse and Crystallization of Saccharide, Protein, and Mannitol Formulations by Optical Fibers in Lyophilization
por: Horn, Jacqueline, et al.
Publicado: (2018)

Lyophilized Drug-Loaded Solid Lipid Nanoparticles Formulated with Beeswax and Theobroma Oil
por: Amekyeh, Hilda, et al.
Publicado: (2021)

Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations
por: Szente, Lajos, et al.
Publicado: (2021)

Case report: Somatic mutations in microtubule dynamics-associated genes in patients with WNT-medulloblastoma tumors
por: Skitchenko, Rostislav, et al.
Publicado: (2023)

PC 386/486 y pentium software estándar
por: Maass, K. 1961- (Klauss)
Publicado: (1994)

Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
por: Thalen, Marcel, et al.
Publicado: (2020)

mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase
por: Koo, Grace, et al.
Publicado: (2022)

Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)

MON-386 Finding Truth from Two False-Positives
por: Imam, Ahmad, et al.
Publicado: (2019)

SUN-386 Problems In Adrenal Incidentaloma Diagnostics In Clinical Practice
por: Davidenko, Ilia, et al.
Publicado: (2019)

386. Long-term Complications Associated with COVID-19 Infection
por: Gudipati, Smitha, et al.
Publicado: (2020)

386 Impact of telehealth appointments on pharmaceutical management of dermatological conditions
por: Munjal, A., et al.
Publicado: (2022)

Development of lyophilization cycle and effect of excipients on the stability of catalase during lyophilization
por: Lale, Shantanu V, et al.
Publicado: (2011)

Effects of Processing and Storage on Pediococcus pentosaceus SB83 in Vaginal Formulations: Lyophilized Powder and Tablets
por: Borges, Sandra, et al.
Publicado: (2013)

A lyophilized surfactant-based rutin formulation with improved physical characteristics and dissolution for oral delivery
por: Yusuf, Helmy, et al.
Publicado: (2023)

Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma
por: Wang, Jing-hua, et al.
Publicado: (2016)

Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma
por: Fu, Ruiying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jl0o9le85ffa6qjadpj047d5fd